Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments

Chandana B Herath; Peter W Angus; Jonel Trebicka

doi:10.3389/fphys.2022.864083

Editorial: Portal Hypertension in Cirrhosis: From Pathogenesis to Novel Treatments

Front Physiol. 2022 Mar 21:13:864083. doi: 10.3389/fphys.2022.864083. eCollection 2022.

Authors

Chandana B Herath¹, Peter W Angus², Jonel Trebicka³

Affiliations

¹ Ingham Institute for Applied Medical Research, South Western Sydney Clinical School, University of New South Wales, Liverpool, NSW, Australia.
² Department of Gastroenterology, Austin Health, University of Melbourne, Melbourne, VIC, Australia.
³ Translational Hepatology, Medical Department, University of Frankfurt, Frankfurt, Germany.

No abstract available

Keywords: cirrhosis; liver stiffness measurement (LSM); macrophage activation markers; novel treatment; pathophysiology of cirrhosis; portal hypertension; portal vein thrombosis (PVT); transjugular intrahepatic portosystemic shunts.

Publication types

Editorial